Ceribell to Participate in the William Blair 45th Annual Growth Stock Conference

Rhea-AI Summary

Ceribell (NASDAQ: CBLL), a medical technology company specializing in neurological condition diagnosis and management, has announced its participation in the William Blair 45th Annual Growth Stock Conference. CEO and Co-founder Jane Chao, Ph.D., will deliver a presentation on Tuesday, June 3, 2025, at 7:20 a.m. PST / 9:20 a.m. CST. Investors can access both live and archived versions of the presentation through the company's investor relations website at https://investors.ceribell.com/.

News Market Reaction – CBLL

-3.47%

1 alert

-3.47% News Effect

On the day this news was published, CBLL declined 3.47%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

SUNNYVALE, Calif., May 20, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today announced that Jane Chao, Ph.D., CEO and Co-founder, will present at the upcoming William Blair 45^th Annual Growth Stock Conference. The presentation will take place on Tuesday, June 3, 2025, at 7:20 a.m. Pacific Standard Time / 9:20 a.m. Central Standard Time. 

Event: William Blair 45^th Annual Growth Stock Conference
Date: Tuesday, June 3, 2025
Time: 7:20 a.m. PST / 9:20 a.m. CST

A live and archived webcast of the presentation will be available in the "Investor Relations" section of the Ceribell website at https://investors.ceribell.com/. 

About CeriBell, Inc.
Ceribell is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. Ceribell has developed the Ceribell System, a novel, point-of-care electroencephalography (“EEG”) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, highly portable, and rapidly deployable hardware with sophisticated artificial intelligence (“AI”)-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. The Ceribell System is FDA-cleared for detecting suspected seizure activity and currently utilized in intensive care units and emergency rooms across the U.S. Ceribell is headquartered in Sunnyvale, California. For more information, please visit www.ceribell.com or follow the company on LinkedIn.

Investor Contact
Brian Johnston or Laine Morgan
Gilmartin Group
Investors@ceribell.com 

Media Contact
Corrie Rose
Press@ceribell.com

FAQ

When is Ceribell (CBLL) presenting at the William Blair Growth Stock Conference 2025?

Ceribell will present at the William Blair Conference on Tuesday, June 3, 2025, at 7:20 a.m. PST / 9:20 a.m. CST.

Who will represent Ceribell (CBLL) at the William Blair Conference 2025?

Jane Chao, Ph.D., CEO and Co-founder of Ceribell, will present at the conference.

How can investors watch Ceribell's (CBLL) presentation at the William Blair Conference?

Investors can access the live and archived webcast through Ceribell's investor relations website at https://investors.ceribell.com/.

What is Ceribell's (CBLL) main business focus?

Ceribell is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions.